Literature DB >> 2795139

Opiate influences on nucleus accumbens neuronal electrophysiology: dopamine and non-dopamine mechanisms.

R L Hakan1, S J Henriksen.   

Abstract

Single-unit recordings of nucleus accumbens septi (NAS) neurons in halothane-anesthetized rats revealed that microinfusions of morphine into the ventral tegmental area (VTA) primarily inhibited spontaneously active NAS units. These inhibitory effects were reversed by alpha-flupenthixol (s.c.), suggesting a role for dopamine (DA) in the observed opiate-induced effect. VTA opiate microinfusions also inhibited the evoked (driven) responses of silent cells (spontaneously inactive) in the NAS elicited by stimulation of hippocampal afferents to the NAS. In addition, this inhibition of driven response was reversed by naloxone (s.c.) but not by alpha-flupenthixol, implying a VTA-mediated non-DA mechanism. Morphine applied iontophoretically to cells within the NAS inhibited spontaneous activity but not fimbria-driven cellular activity, suggesting that the systemic effects of opiates on NAS activity can be mediated directly in the NAS as well as through VTA afferents. Moreover, since VTA-induced inhibition of fimbria-driven activity was reversed by systemic opiates, opiates also can exert effects through other, as yet unidentified NAS afferent systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2795139      PMCID: PMC6569907     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  14 in total

1.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition.

Authors:  Ja Wook Koo; Mary Kay Lobo; Dipesh Chaudhury; Benoit Labonté; Allyson Friedman; Elizabeth Heller; Catherine Jensen Peña; Ming-Hu Han; Eric J Nestler
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

3.  Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats.

Authors:  Minh P Lam; Harri Nurmi; Noora Rouvinen; Kalervo Kiianmaa; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2009-11-26       Impact factor: 4.530

4.  Intra-accumbal Cannabinoid Agonist Attenuated Reinstatement but not Extinction Period of Morphine-Induced Conditioned Place Preference; Evidence for Different Characteristics of Extinction Period and Reinstatement.

Authors:  Hossein Khaleghzadeh-Ahangar; Abbas Haghparast
Journal:  Neurochem Res       Date:  2017-08-05       Impact factor: 3.996

5.  Gabapentin completely attenuated the acute morphine-induced c-Fos expression in the rat nucleus accumbens.

Authors:  Jamil Ahsan Kazi; Mohamed Ibrahim Abu-Hassan
Journal:  J Mol Neurosci       Date:  2010-08-24       Impact factor: 3.444

6.  The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat.

Authors:  M Dziedzicka-Wasylewska; R Rogoz
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 7.  In vivo analysis of the role of dopamine in stimulant and opiate self-administration.

Authors:  A Gratton
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

Review 8.  Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.

Authors:  William A Carlezon; Mark J Thomas
Journal:  Neuropharmacology       Date:  2008-07-15       Impact factor: 5.250

9.  Opioid and GABA modulation of accumbens-evoked ventral pallidal activity.

Authors:  J J Chrobak; T C Napier
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration.

Authors:  Peter W Marinelli; Rémi Quirion; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.